1. Cerceo, E, Deitelzweig, SB, Sherman, BM, Amin, AN. Multidrug-resistant gram-negative bacterial infections in the hospital setting: Overview, Implications for clinical practice, and emerging treatment options. Microb Drug Resist. 2016;22(5):412-431.
Google Scholar | Crossref | Medline2. Ikonomidis, A, Pournaras, S, Maniatis, AN, Legakis, NJ, Tsakris, A. Discordance of imipenem versus imipenem activity against acinetobacter baumannii. Int J Antimicrob Agents. 2006;l4:376-377.
Google Scholar | Crossref3. Hoffman, J, Trimble, J, Brophy, GM. Safety of imipenem/cilastatin in neurocritical care patients. Neurocrit Care. 2009;10(3):403-407.
Google Scholar | Crossref | Medline4. Mouton, JW, Touzw, DJ, Horrevorts, AM, Vinks, AA. Comparative pharmacokinetics of the carbapenems: Clinical implications. Clin Pharmacokinet. 2000;39(3):185-201.
Google Scholar | Crossref | Medline | ISI5. Lipš, M, Siller, M, Strojil, J, Urbánek, K, Balík, M, Suchánková, H. Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: A comparison of 0.5-h and 3-h infusions. Int J Antimicrob Agents. 2014;44(4):358–362.
Google Scholar | Crossref | Medline6. Trissel, L, Xu, QA. Stability of imipenem-cilastatin sodium in autodose infusion system bags. Hosp Pharm. 2003;38(2);130-134.
Google Scholar | SAGE Journals7. Shabir, GA . A practical approach to validation of HPLC methods under current good manufacturing practices. J Validation Technol 2004;10(3):210-218.
Google Scholar8. Chromatography, Validation of Compendia Preocedures, Verification of Compendia Procedures. USP 36-NF 31. Rockville, MD: United States Pharmacopeial Convention; 2013:621-1226.
Google Scholar9. Van Herendael, B, Jeurissen, A, Tulkens, PM, et al. Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin? Ann Intensive Care. 2012;2(1):22.
Google Scholar | Crossref | Medline10. Fawaz, S, Barton, S, Whitney, L, Swinden, J, Nabhani-Gebara, S. Stability of meropenem after reconstitution for administration by prolonged infusion. Hosp Pharm. 2019;54(3):190-196.
Google Scholar | SAGE Journals | ISI11. Swanson, DJ, Deangelis, C, Smith, IL, Schentag, JJ. Degradation kinetics of imipenem in normal saline and in human serum. Antimicrobial agents and chemotherapy. 1986;29(5): 936-937.
Google Scholar | Crossref | Medline12. Srinivasan, R, Mary, KL, Kumar, DR, Chandana, P. A new RP-HPLC method for the simultaneous estimation of imipenem and cilastatin in pharmaceutical dosage form. Int J Adv Pharmaceut Sci. 2014;5:2400-2404.
Google Scholar13. The United States Pharmacopeia, 30 Th rev., and the National Formulary. 25th ed. Rockville, MD: The United States Pharmacopeial Convention; 2006:321-327.
Google Scholar14. Keel, RA, Sutherland, CA, Crandon, JL, Nicolau, DP. Stability of doripenem, imipenem and meropenem at elevated room temperatures. Int J Antimicrob Agents. 2011;37(2):184-185.
Google Scholar | Crossref | Medline15. Viaene, E, Chanteux, H, Servais, H, Mingeot-Leclercq, MP, Tulkens, PM. Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrob Agents Chemother. 2002;46(8):2327-2332.
Google Scholar | Crossref | Medline